AstraZeneca (NYSE: AZN) and Targacept, Inc. (NASDAQ: TRGT) announced top-line results from a Phase IIb clinical trial ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE